戻る Agendas
PHARMACOVIGILANCE: HOW WELL ARE PATIENTS INFORMED AND HOW CAN THEY CONTRIBUTE?
Session Chair(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom
Pharmacovigilance and Patient Information - What's new?
Learning Objective : - Discuss the impact of patients' preferences for the structuring of patient leaflets - Identify the evidence for the use of a key information section in patient leaflets - Appraise the readability of recommendations for safety wordings from PRAC
Speaker(s)
Pharmacovigilance and Patient Information - What's new?
D.K.Theo Raynor, PHD, MPHARM
University of Leeds, United Kingdom
Professor of Pharmacy Practice
The Patient Information Gap
Phil Willan
Healthcare Quality Improvement Partnership (HQIP), United Kingdom
Patient Representative
Using Patient Insights to Improve Safety Management
Michael Richardson, MD, FFPM, FRCP
Bristol-Myers Squibb, United Kingdom
Senior Vice President, WorldWide Patient Safety